KALA — KALA BIO Balance Sheet
0.000.00%
Last trade - 00:00
- $30.14m
- $16.17m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 85.4 | 154 | 92.1 | 70.5 | 50.9 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 13.1 | 9.85 | 17.5 | 1.1 | 0.236 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 105 | 171 | 124 | 85.9 | 52.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 32.5 | 31 | 4.02 | 0.416 | 2.78 |
Other Long Term Assets | |||||
Total Assets | 154 | 222 | 139 | 86.8 | 55.9 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 24.8 | 22.2 | 37.4 | 25.7 | 8.35 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 125 | 122 | 123 | 67.8 | 48.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 29.7 | 100 | 16.8 | 19 | 7.5 |
Total Liabilities & Shareholders' Equity | 154 | 222 | 139 | 86.8 | 55.9 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |